Share
WASHINGTON, D.C. – May 25, 2021 – The former U.S. Department of Health and Human Services (HHS) General Counsel, Robert P. Charrow, has returned to the Washington, D.C. office of global law firm Greenberg Traurig, LLP. Charrow joins as senior chairman of the firm’s Health Care & FDA Practice.
“Bob is a proven leader and key figure in the health care industry. Indeed, he was previously a valued leader and part of the firm s cultural and quality fabric his first time with us. Having him rejoin at this time speaks to his and our commitment to Washington, D.C. and to the many stakeholders in an industry thrust into the limelight by the global health crisis - as well as our ability to serve the many private equity investors so active in the space,” said Richard A. Rosenbaum, Greenberg Traurig’s Executive Chairman. “Bob’s return to Greenberg Traurig is one aspect of our strategy to grow in elite areas of practice in which we are already recognized as best in class
Share this article
Share this article
WASHINGTON, May 25, 2021 /PRNewswire/ The former U.S. Department of Health and Human Services (HHS) General Counsel, Robert P. Charrow, has returned to the Washington, D.C. office of global law firm Greenberg Traurig, LLP. Charrow joins as senior chairman of the firm s Health Care & FDA Practice. Bob is a proven leader and key figure in the health care industry. Indeed, he was previously a valued leader and part of the firm s cultural and quality fabric his first time with us. Having him rejoin at this time speaks to his and our commitment to Washington, D.C. and to the many stakeholders in an industry thrust into the limelight by the global health crisis - as well as our ability to serve the many private equity investors so active in the space, said Richard A. Rosenbaum, Greenberg Traurig s Executive Chairman. Bob s return to Greenberg Traurig is one aspect of our strategy to grow in elite areas of practice in which we are already recog
Former HHS GC Robert P Charrow Returns To Greenberg Traurig In Washington, D C prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
By
Greenberg Traurig LLP issued the following announcement on Apr. 14.
Charles Andres, a shareholder in global law firm Greenberg Traurig, LLP’s Intellectual Property & Technology, Patent Prosecution, Healthcare & FDA , and Life Sciences & Medical Technology Practices, has joined the Lexis Practical Guidance (PG) Life Sciences Advisory Board. The board aims to offer guidance on various issues as it reviews and discusses current trends in law, practice areas, and the market.
Andres, who is based in Greenberg Traurig’s Washington, D.C. office, is a registered patent attorney focused on patent prosecution, strategic patent counseling, IP due diligence, drug and medical device FDA regulatory counseling, invalidity and non-infringement opinions, life-cycle management, Supreme Court and Federal Circuit amicus briefs, transactional work, and related business matters. A trusted advisor, Andres has been invited to speak at conferences and programs worldwide. In addition, he ha
Greenberg Traurig’s Charles Andres Joins Lexis Practical Guidance Life Sciences Board
Share Article
Charles Andres, a shareholder in global law firm Greenberg Traurig, LLP’s Intellectual Property & Technology, Patent Prosecution, Healthcare & FDA , and Life Sciences & Medical Technology Practices, has joined the Lexis Practical Guidance (PG) Life Sciences Advisory Board. WASHINGTON (PRWEB) April 15, 2021
Charles Andres, a shareholder in global law firm Greenberg Traurig, LLP’s Intellectual Property & Technology, Patent Prosecution, Healthcare & FDA, and Life Sciences & Medical Technology Practices, has joined the Lexis Practical Guidance (PG) Life Sciences Advisory Board. The board aims to offer guidance on various issues as it reviews and discusses current trends in law, practice areas, and the market.